Analyst Price Targets — IRTC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 15, 2026 12:33 pm | Richard Newitter | Truist Financial | $170.00 | $123.96 | TheFly | iRhythm price target lowered to $170 from $200 at Truist |
| February 23, 2026 11:45 am | — | Goldman Sachs | $184.00 | $150.96 | TheFly | iRhythm price target lowered to $184 from $211 at Goldman Sachs |
| February 20, 2026 2:15 pm | Richard Newitter | Truist Financial | $200.00 | $147.77 | StreetInsider | iRhythm Technologies (IRTC) PT Lowered to $200 at Truist Securities |
| February 20, 2026 12:01 pm | — | Robert W. Baird | $200.00 | $158.88 | TheFly | iRhythm price target lowered to $200 from $220 at Baird |
| January 13, 2026 12:22 pm | — | Wells Fargo | $225.00 | $168.99 | TheFly | iRhythm price target raised to $225 from $220 at Wells Fargo |
| January 9, 2026 10:50 am | — | Goldman Sachs | $211.00 | $189.25 | TheFly | iRhythm price target raised to $211 from $202 at Goldman Sachs |
| January 5, 2026 11:19 am | Vijay Kumar | Evercore ISI | $210.00 | $175.22 | TheFly | iRhythm upgraded to Outperform from In Line at Evercore ISI |
| December 18, 2025 2:10 pm | — | Truist Financial | $215.00 | $172.07 | TheFly | iRhythm price target lowered to $215 from $230 at Truist |
| December 2, 2025 11:37 am | — | Morgan Stanley | $205.00 | $182.74 | TheFly | iRhythm price target raised to $205 from $195 at Morgan Stanley |
| October 31, 2025 1:12 pm | David Roman | Goldman Sachs | $202.00 | $192.62 | TheFly | iRhythm price target raised to $202 from $180 at Goldman Sachs |
Latest News for IRTC
SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2026 after the close of trading on Thursday, April 30, 2026. The company's management team will host a corresponding conference call…
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
NEW YORK, April 9, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at iRhythm caused the company to misrepresent or fail to disclose that the Zio AT monitor was a real-time monitor intended…
MSP Recovery (NASDAQ: MSPR - Get Free Report) and iRhythm Technologies (NASDAQ: IRTC - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Profitability This table compares MSP Recovery and iRhythm
iRhythm rides strong volume growth, AI-driven innovation and primary care expansion, but reimbursement pressure and rising competition cloud the outlook.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.